Ex-OpenAI exec launches ChronicleBio to use AI against diseases with zero FDA-approved therapies
jeremy_goldberg · x · 2026-10-02
ChronicleBio, founded by a former OpenAI executive, was featured by Forbes. It targets complex chronic conditions — POTS, Long COVID, ME/CFS and hEDS — affecting hundreds of millions of people who currently have exactly zero FDA-approved therapies.
The plan: build the deepest dataset on these conditions, apply AI to uncover the biology behind the symptoms, and match the right drugs to the right patients.
More from Apps
- a16z teases seventh Consumer AI Top 100 list, using Assistant Benchmark data — omooretweets · 2026-10-02
- Shopify launches Canvas: AI Sidekick redesigns your entire store at once — gaganghotra_ · 2026-10-02
- "Microsoft is cosplaying AI": user rants Copilot is a chatbot pasted everywhere — YoungDito · 2026-10-02
- How Evan Crawley built the viral phone-to-phone QR file transfer in one night with Claude Code — n3rder · 2026-10-02
- AI circle debates personal assistants: KOL says most people don't care about productivity, family assistants are the real opportunity — tokumin · 2026-10-02
- A designer's take on the tools and workflow that make AI design actually fun — Rasmic · 2026-10-02